Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study-Reference-Cited by-同舟云学术

Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study

Published:2014-03-28 Issue:4 Volume:66 Page:1034-1043
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Vastert Sebastiaan J.¹,de Jager Wilco¹,Noordman Bo Jan¹,Holzinger Dirk²,Kuis Wietse¹,Prakken Berent J.¹,Wulffraat Nico M.¹

Affiliation:

1. University Medical Centre Utrecht; Utrecht The Netherlands

2. University Children's Hospital Muenster and University of Muenster; Muenster Germany

Funder

Federal Ministry of Education and Research

Dutch Arthritis Foundation

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.38296/fullpdf

Reference48 articles.

1. Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome;Woo;Nat Clin Pract Rheumatol,2006

2. Juvenile idiopathic arthritis;Prakken;Lancet,2011

3. New insights in systemic juvenile idiopathic arthritis: from pathophysiology to treatment;Frosch;Rheumatology (Oxford),2008

4. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?;Ramanan;Rheumatology (Oxford),2005

5. Systemic JIA: new developments in the understanding of the pathophysiology and therapy;Vastert;Best Pract Res Clin Rheumatol,2009

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The past 25 years in paediatric rheumatology: insights from monogenic diseases;Nature Reviews Rheumatology;2024-08-07

2. Anakinra as first-line monotherapy for new-onset steroid-naïve sJIA patients;Expert Review of Clinical Immunology;2024-07-30

3. A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis;Best Practice & Research Clinical Rheumatology;2024-07

4. Novel therapies in juvenile idiopathic arthritis;Current Opinion in Rheumatology;2024-05-23

5. Predictors of disease course in systemic juvenile idiopathic arthritis;Modern Rheumatology;2024-04-08